Bryan Stringham, DO
Otolaryngology/Facial Plastic Surgery · Marietta, GANPI 1801052071
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,637 of the $5,084 with a category attached, or 71.5%. 19 manufacturers reported payments, led by Aerin Medical Inc. at 42.0% of the total. Reporting peaked in 2024 at $2,561 and has fallen 68.6% since, to $804 in 2025. Among otolaryngology/facial plastic surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $35.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$2K
- Sanofi$963
- Optinose US, Inc.$513
- GSK$421
- Regeneron Healthcare Solutions, Inc.$278
- Stryker$183
- plus $593 from 13 others
What the payments were for
- Travel & lodging$1,30226%
- Food & beverage$3,63772%
- Education$1453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 17 | $2,134 |
| Sanofi | 40 | $963 |
| Optinose US, Inc. | 24 | $513 |
| GSK | 19 | $421 |
| Regeneron Healthcare Solutions, Inc. | 11 | $278 |
| Stryker | 6 | $183 |
| Intersect ENT, Inc. | 7 | $115 |
| Acclarent, Inc | 1 | $104 |
| Medtronic | 3 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| Hikma Pharmaceuticals USA | 3 | $50 |
| Kaleo, Inc. | 3 | $38 |
| Amgen | 1 | $34 |
| Fortovia Therapeutics, Inc. | 2 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| Novartis | 1 | $19 |
| Johnson & Johnson | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,569
- RHINAER STYLUS$150
- NUCALA$117
- DUPIXENT$113
- Xhance$109
- TruDi Nav Cable$104
How this compares
$5,084 in reported general payments places this provider in the 95th percentile of 21 otolaryngology/facial plastic surgery providers in Georgia.
See all otolaryngology/facial plastic surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 817 | $9,015 |
| Azelastine Hcl | 266 | $6,980 |
| Ipratropium Bromide | 206 | $6,369 |
| Epinephrine | 28 | $4,249 |
| Pantoprazole Sodium | 194 | $1,405 |
| Fluocinolone Acetonide Oil | 15 | $484 |
| Montelukast Sodium | 79 | $463 |
| Omeprazole | 26 | $335 |
| Mometasone Furoate | 31 | $330 |
| Famotidine | 42 | $304 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $255 |
| Methylprednisolone | 43 | $144 |
| Mupirocin | 21 | $114 |
| Doxycycline Hyclate | 13 | $106 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $50 | $4,24928 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 otolaryngology/facial plastic surgery providers in Georgia.
Other otolaryngology/facial plastic surgery in Marietta
- Cang NguyenDouglasville$3K
- Timothy MintonSavannah$3K
- Aaron FletcherStockbridge$2K
- Julia KerolusAtlanta$2K
- Shivan AminAtlanta$2K
- Thomas WalkerAtlanta$2K
- Joseph BeeBrunswick$2K
- Karla HansenBrunswick$1K
- Joel AlexanderAtlanta$1K
- Stephen RashleighSavannah$987
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.